Abbott and Beta Bionics are collaborating to integrate Abbott’s upcoming dual glucose-ketone sensor with Beta’s iLet Bionic ...

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc.

Abbott's FreeStyle Libre 3 Plus sensor will be compatible with the twiist AID System, which is expected to launch in Q2 2025. "We are thrilled to announce our collaboration with Abbott, integrating ...

Abbott's FreeStyle Libre 2 system represents a significant advancement in diabetes management. The system continues to be the market leader in Alberta and is Canada's leading sensor-based glucose ...

Abbott's FreeStyle Libre 2 system represents a significant advancement in diabetes management. The system continues to be the market leader in Alberta and is Canada's leading sensor-based glucose ...

ABBOTT PARK, Ill. – Oct. 30, 2024 – Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food ...

Abbott has initiated a voluntary medical device correction for a small number of FreeStyle Libre 3 sensors distributed in the United States during the first half of May 2024. The FreeStyle Libre 3 ...

ACTON, Mass.– (BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it ...

October 11, 2023 By Sean Whooley The FreeStyle Libre 2 continuous glucose monitor (CGM). [Image from Abbott] Abbott (NYSE:ABT) announced today that it released a new FreeStyle Libre 2 app version with ...